Previous reports have linked overexpression of ezrin and prognosis in various cancers, including ovarian carcinoma [31], hepatitis B-related hepatocellular carcinoma [32], non-small-cell lung cancer [33], and CRC [34-36]. This evidence concerns the gene EZR and cancer.